Overview
AMRI
Arevipharma GmbH
Bioindustria L.I.M. Spa
Farmak A.S
Fermion Oy
GfM
Hi-Tis
Inke S.A
Ipochem Ltd
Jetpharma SA
Minakem
Munit SA
PCI Synthesis
Polfa Tarchomin S.A
Quality Chemicals
ScinoPharm Taiwan, Ltd
Siegfried AG
ZCL Chemicals Limited
CZECH REPUBLIC
FINLAND
FRANCE
GERMANY
INDIA
ITALY
POLAND
SPAIN
SWITZERLAND
TAIWAN
UNITED STATES
- Service Details
Hi-Tis is dedicated to the micronization of active ingredients for the pharmaceutical, veterinary, food, cosmetic and nutraceutical industries. They have extensive experience in micronization and other solid treatments of APIs.
- Service Details
Minakem's key technologies include Solid State characterisation, Particle size management, Micronization, Chiral chemistry, Cyanidation, Hydrogenation, Hazardous chemistry, Continuous Flow Chemistry & Multi-steps synthesis.
Development, production, marketing of APIs, Intermediates & specialities// FDA inspected.
- Service Details
Farmak, a.s. utilizes these standard types of reactions with full GMP manufacturing conditions; finalization of powder substances (sieving, grounding, micronization), high-temperature reactions up to 300°C, low-pressure hydrogenation (up to 3 bar), etc.
- Service Details
Four multi-purpose cGMP manufacturing plants have reaction capacity of 214 KL with 72 reactors - 34 Stainless Steel reactors, 37 Glass Lined reactors and Micronizer Air Jet mill and Multi-mill (for particle size reduction).
A partner for the pharma and biotech industries to improve patient outcomes & quality of life
- Service Details
AMRI offers more than 240 high-quality, competitively priced APIs and intermediates, including generics, that cover a variety of therapeutic areas. Their key products of steroids, hormones have micronization facility.
A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
- Service Details
ScinoPharm's all 16 units have their own dedicated filtration/drying/milling/and packaging facilities. Several multiple-use drying and finishing units are available to reduce intermediate bottlenecks and all have been validated for API/CGMP operations.
Neuraxpharm's APIs manufacturing plant.
- Service Details
Inke has more than 20 years of experience in differentiated micronisation capabilities.They provide process control of micronisation grades achieved to ensure that each active ingredient conforms to custom particle size distribution specifications.
Begin the journey of your innovative API with Fermion.
- Service Details
Fermion's Hanko plant has 3 production units with a total of 240 m3 reactor capacity with a choice of reactors from 1000 lit to 6300 lit, they have a fully automated API production with a separate micronization area.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
- Service Details
We are willing to listen to requests and gather nuances and, above all, we have a very huge vision of the possible answers and solutions.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
- Service Details
Apart from the manufacturing of active pharmaceutical ingredients and its intermediates under cGMP conditions, Arevipharma offers the sieving, mixing, milling, and micronising for any desired particle size distribution.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
- Service Details
Biondustria L.I.M. is highly competitive in the field of A.P.I. synthesis requiring high technology processes.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
- Service Details
PCI Synthesis' Devens site is fully equipped with on-site analytical equipment, including micronization.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
- Service Details
Ipochem represents experience and proficiency in the chemical and pharmaceutical industry. Technologies and capabilities include the development and production of APIs as well as physical operations of milling and micronization.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
- Service Details
To prevent the degradation of highly sensitive products, to avoid polymorphic changes, to avoid an increase in amorphous particles, to allow the micronization of polymers.